Shraddha Institute of Pharmacy, Kondala Zambre Washim, Maharashtra India- 444505
This study presents the development and evaluation of a novel cinnamon-based roll-on formulation for the effective management of primary dysmenorrhoea. Enriched with potent bioactive compounds cinnamaldehyde and eugenol extracted from cinnamon essential oil, the formulation exhibits notable analgesic, anti-inflammatory, and antispasmodic properties. Comprehensive physicochemical and microbiological analyses confirmed its stability, safety, and non-irritant nature, supporting its potential for consumer use. The roll-on design offers a convenient, non-invasive mode of application, enabling rapid and localized relief from menstrual cramps by directly targeting the underlying causes rather than masking symptoms. As a natural, cost-effective alternative to conventional therapies, this formulation addresses the growing demand for safe, plant-based solutions in women’s health. With further validation, the cinnamon roll-on could redefine menstrual pain management and contribute meaningfully to integrative healthcare.
Dysmenorrhoea, or menstrual pain, is a prevalent condition among menstruating individuals, often resulting in significant discomfort and a reduced quality of life. The standard medical approach typically involves non-steroidal anti-inflammatory drugs (NSAIDs), which, although effective, may cause unwanted effects with prolonged use. Chronic inflammation, a key player in many long-term illnesses, similarly demands therapeutic strategies that are both effective and safe. In response, the medical community has increasingly turned its attention to plant-based and alternative remedies, seeking out natural therapies with fewer side effects.[1] NSAIDs and hormonal contraceptives remain the cornerstone treatments for primary Dysmenorrhoea. Despite their effectiveness in managing pain, these interventions frequently cause gastrointestinal irritation and other adverse reactions. Moreover, not all patients achieve relief from conventional therapy, prompting the exploration of alternative treatments. Similarly, in chronic inflammatory diseases, the reliance on conventional drugs can lead to complications, making safer therapeutic alternatives highly desirable.[2] NSAIDs are typically the first line of treatment for Dysmenorrhoea, but their usage is often associated with side effects such as dizziness, dyspepsia, headaches,[3] nausea, allergic reactions, mood alterations, bleeding tendencies, metabolic imbalances, and even severe outcomes like malignancy or death in rare cases.[4] Hormonal therapies, such as oral contraceptives, are also used as a secondary or alternative intervention. These agents reduce prostaglandin levels and alleviate menstrual pain, but can also cause side effects like irregular bleeding, headaches, nausea, mood shifts, and weight fluctuations, which often result in poor compliance among users[5,6]. Herbal remedies have long been utilized across civilizations for treating various ailments, and cinnamon—sourced from the bark of trees in the Cinnamomum genus is a prime example of such a plant. Known for its culinary applications, cinnamon also offers medicinal benefits due to its antioxidant, antimicrobial, and anti-inflammatory actions. Its potential role in alleviating menstrual pain and related symptoms has been increasingly validated through scientific studies[7]. Topical formulations present a promising delivery method, allowing active ingredients to act directly on affected areas, minimizing systemic exposure and associated risks. Among these, roll-on products are especially favored for their convenience, targeted application, and portability. A roll-on using cinnamon oil could combine these benefits with the therapeutic properties of cinnamon, offering a new and practical approach to treating Dysmenorrhoea and localized inflammation.
This research focuses on formulating and evaluating a cinnamon-based roll-on intended to address Dysmenorrhoea, inflammation, and other associated conditions. The specific goal is to develop a stable and effective roll-on product capable of delivering localized relief with minimal side effects.
Primary dysmenorrhoea refers to menstrual pain that occurs in the absence of identifiable pelvic pathology and affects up to 90% of menstruating individuals, particularly adolescents and young women.[8] The pathophysiology primarily involves elevated production of uterine prostaglandins, especially prostaglandin F2α (PGF?α) and prostaglandin E2 (PGE?), which stimulate excessive uterine contractility, vasoconstriction, and localized ischemia culminating in pain and discomfort.[9] Cinnamon, derived from Cinnamomum zeylanicum and Cinnamomum cassia, has been traditionally employed in the management of gynecological conditions. Recent scientific evidence supports its therapeutic potential in primary dysmenorrhoea owing to its analgesic, anti-inflammatory, antioxidant, and smooth muscle-relaxant properties.[10]
Cinnamon exerts a critical pharmacological effect by modulating the prostaglandin synthesis pathway. Bioactive constituents such as cinnamaldehyde, cinnamic acid, and eugenol demonstrate selective inhibition of cyclooxygenase-2 (COX-2), thereby attenuating the biosynthesis of PGF?α and PGE?.[11,12] Experimental models have confirmed that cinnamaldehyde significantly suppresses COX-2 gene expression, resulting in reduced prostaglandin levels and subsequent inflammation.[13] This mechanism mirrors the action of non-steroidal anti-inflammatory drugs (NSAIDs) but with potentially fewer adverse gastrointestinal effects.[14]
Cinnamon is a rich source of polyphenolic compounds that downregulate key pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6), which are closely linked to endometrial inflammation during menstruation.[15,16] The anti-inflammatory action helps alleviate pain by mitigating cytokine-induced uterine irritation. [17] Moreover, its antioxidant constituents such as flavonoids and tannins neutralize reactive oxygen species (ROS), thereby reducing oxidative stress in endometrial tissue, a condition known to amplify inflammatory responses and worsen dysmenorrhoeic symptoms.[18,19]
Uterine smooth muscle contractility is mediated by intracellular calcium (Ca²?) influx. Cinnamon has been shown to inhibit voltage-gated calcium channels, thereby decreasing intracellular calcium concentrations and reducing the intensity of uterine contractions.[20]Furthermore, it suppresses the activity of myosin light chain kinase (MLCK), a Ca²?-dependent enzyme that facilitates myometrial contraction, promoting uterine relaxation and pain relief .[21]
Emerging evidence suggests that cinnamon may also influence central mechanisms of pain perception. It has been reported to increase β-endorphin levels—endogenous opioids that bind to μ-opioid receptors, diminishing nociceptive transmission and promoting analgesia. Additionally, cinnamon may modulate neurotransmitters such as serotonin and dopamine, which play essential roles in regulating mood, stress response, and menstrual-related pain. [32]
PLANT PROFILE
Cinnamon is an aromatic spice derived from the inner bark of trees classified under the genus Cinnamomum, which belongs to the Lauraceae family. Among the most commonly used species for spice production are Cinnamomum verum (also known as true or Ceylon cinnamon) and Cinnamomum cassia (commonly referred to as cassia or Chinese cinnamon). Other significant species include Cinnamomum burmannii (Indonesian cinnamon) and Cinnamomum loureiroi (Vietnamese or Saigon cinnamon).
Cinnamon is a perennial evergreen tree or shrub classified under the Lauraceae family. In natural settings, it can attain a height ranging from 10 to 15 meters, although cultivated specimens are typically pruned to shorter sizes to facilitate easier harvesting. It possesses a robust taproot system that provides structural support and stability. The trunk is upright, cylindrical, and woody, often exhibiting dense branching. Commercial interest centers around the bark—while the outer bark is coarse and greyish-brown in appearance, the inner bark is smooth, thin, aromatic, and light brown in color.
The characteristic scent and flavor of cinnamon are primarily due to its essential oil content, with cinnamaldehyde serving as the dominant constituent—comprising approximately 60% to 90% of the oil, depending on the species.
Cinnamon has been extensively studied for its medicinal potential in the management of primary dysmenorrhoea. Cinnamon demonstrates strong antioxidant properties by neutralizing free radicals and mitigating oxidative stress, which contributes to uterine inflammation. Multiple studies have confirmed its anti-inflammatory effects, particularly through its essential oils. Flavonoid compounds such as gossypin, gnaphalin, hesperidin, hibifolin, hypolaetin, oroxindin, and quercetin—isolated from cinnamon—are known to possess significant anti-inflammatory activity. These actions help in reducing uterine inflammation, easing menstrual discomfort, and improving overall menstrual health.
Table no.1: Physical and chemical properties of cinnamon
Property |
Characteristics |
Composition |
Cinnamon bark oil: Cinnemaldehyde (75-90%); linalool, eugenol, cinnamyl acetate, cinnamic acid, cinnamon alcohol, various other terpenoids |
Physical state at 25°C |
Liquid (oil), Solid (powder) |
Colour |
Dark brown |
Odour |
Distinct cinnamon spice aroma (cinnamon bark oil) |
Solubility |
Soluble at 10% in ethyl alcohol . soluble in most vegetable oils and glacial acetic acid. Soluble in propylene glycol. Slightly soluble in water. Insoluble in glycerin, mineral oil. |
Table no. 2: Pharmacokinetic profile
Parameters |
Description |
Absorption |
Transdermal absorption via the skin. |
Distribution |
Primarily localized in skin and subdermal tissues, minimal systemic distribution |
Excretion |
Mostly metabolized locally, minimal renal or hepatic elimination due to limited systemic absorption. |
Table no.3: Pharmacodynamics Profile
Mechanism of action |
Effect |
Key components |
Anti-inflammatory |
Inhibits pro-inflammatory enzymes like COX-2 and INOS, reducing the synthesis of inflammatory mediators. |
CinnamaIdehyde, Eugenol |
Antioxidant |
Scavenges free radicals and prevents lipid peroxidation, helping to protect skin and muscle tissue. |
Polyphenols, Cinnamic acid |
Analgesic |
Modulate TRPV1 and TRPA1 ion channel, reduce peripheral nerve sensitivity. |
Cinnamaldehyde |
MATERIALS AND METHODS
Table no. 4 : Formulation table
INGREDIENTS |
F1 |
F2 |
F3 |
PURPOSE |
Cinnamon Extract |
1.0 ml |
1.5 ml |
2 ml |
Analgesic and anti-inflammatory agent |
Peppermint oil |
0.3 ml |
0.3 ml |
0.3 ml |
Analgesic, antispasmodic, and muscle-relaxant properties. |
Menthol Crystal |
0.1 g |
0.1 g |
0.1 g |
Enhances cooling and pain-relieving effects. |
Camphor oil |
0.3 ml |
0.3 ml |
0.3 ml |
Counter-irritant and warming effect |
Methyl paraben |
0.02 g |
0.02 g |
0.02 g |
Preservative |
Coconut oil |
3.0 ml |
2.8 ml |
2.5 ml |
Primary carrier oil. improves skin penetration. |
Lavender oil |
0.5 ml |
0.5 ml |
0.5 ml |
Calming, analgesic, and anti-inflammatory effects. |
Jojoba oil |
1 ml |
0.9 ml |
0.8 ml |
Enhances absorption, anti-inflammatory and moisturizing effects. |
Almond oil |
2 ml |
1.8 ml |
1.5 ml |
Provides skin nourishment and improves the spreadability of the roll-on. |
Olive oil |
- |
- |
- |
|
RESULT AND DISCUSSION
The cinnamon-based roll-on formulation exhibited excellent physicochemical properties. The appearance was clear and uniform, with no visible phase separation or particulate matter. The color was consistent, showing a light yellowish brown shade, characteristic of cinnamon oil. The roll-on had a pleasant, sweet, and spicy fragrance, indicating the stability and presence of volatile components like cinnamaldehyde. The density was found to be within the acceptable range of 0.9 ensuring good consistency and ease of application. The volatile oil content remained stable, and no signs of rancidity or odor changes were observed during preliminary stability testing. Overall, the cinnamon-based roll-on passed all physicochemical evaluations, indicating it is stable.
Table no. 5: Physicochemical evaluation
Parameters |
Specifications |
Result |
Appearance |
Clear |
Clearandtransparent |
Colour |
Clear to pale yellow brown |
Pale yellow brown tint |
Fragrant |
Pungent |
Pungent |
Density(25°) |
0.95-1.2g/cm3 |
0.9/cm3 |
Solubility |
Slightly soluble in alcohol and insoluble in water |
Slightly soluble in alcohol and essential oil Insoluble in water |
Fig no.1 : Cinnamon powder and Roll-on
Table no.6: Stability testing
Time |
Week 0 |
Week 1st |
Week 2nd |
Room temperature |
Pale yellow colour, with pungent colour |
Pale yellow colour, with pungent colour |
Pale yellow colour, with pungent colour |
Temperature below 20° |
Pale yellow colour, with pungent colour |
Pale yellow colour, with pungent colour |
Pale yellow colour, with pungent colour |
Temperature 40° |
Pale yellow colour, with pungent colour |
Pale yellow colour, with pungent colour |
Pale yellow colour, with pungent colour |
Degradation of product |
No |
No |
No |
The cinnamon roll-on formulation exhibited good stability across various temperatures. At 4°C, the product remained physically stable with no phase separation. At 25°C, it maintained its appearance, fragrance, and therapeutic efficacy throughout the study period. Even under accelerated conditions (40°C), only minimal changes were observed, with no significant loss of volatile oils or product integrity is essential to establish shelf life, optimize formulation stability, and determine appropriate storage recommendations.
Fig no 2 :Under Refrigerator condition
The clarity test was performed to assess the physical uniformity and visual appearance of the cinnamon-based roll-on formulation. The formulation was observed against a black and white background under adequate lighting. It appeared completely clear and transparent, with no visible particulate matter, phase separation, or turbidity. The absence of suspended particles and any signs of crystallization indicated that all ingredients were uniformly dissolved or dispersed within the formulation.
Table no. 7: Clarity test
Batch |
Specifications |
Result |
F1 |
Clear |
Clear |
F2 |
Clear |
Clear |
F3 |
Clear |
Clear |
Fig no. 3 : Clarity test
Clarity refers to the transparency or clearness of a formulation. It is an essential aesthetic and quality parameter, especially for semi-solid or liquid topical products. A clear formulation is often perceived as more appealing and indicates proper solubilization of ingredients.
Table no.8 : Irritability test
Test |
Parameters |
Observation |
Result |
Patch test on Human |
Redness, itching and swelling |
Observe for 24 hours |
No irritation |
Fig no. 4 : Patch irritabilty test
Irritability testing is performed to ensure that the formulation does not cause skin irritation or adverse reactions upon application. This is critical for topical products used on sensitive skin areas, such as during menstruation. The irritation test was conducted to evaluate the skin compatibility of the cinnamon-based roll-on. A small amount of the formulation was applied to the forearm of healthy volunteers and observed over a period of 24 to 48 hours. Throughout the observation period, no signs of redness, itching, swelling, burning sensation, or any other adverse skin reactions were noted. The formulation was well-tolerated, and the volunteers reported a soothing and mild warming effect, which is characteristic of cinnamon oil. Based on these observations, it was concluded that the cinnamon-based roll-on is non-irritant.
Method
Patch Test on Human Volunteers (Ethically approved):
A small amount of formulation is applied to the inner forearm or behind the ear.
The site is covered with a patch for 24 hours.
Redness , Itching and Irritation not occurred.
Table no. 9 : Spredabilty test
Parameters |
Methodology |
Standard |
F1 |
F2 |
F3 |
Spread Diameter |
1g between glass plates, 1kg weight , 1 min |
≥ 5 cm |
6.2 |
5.8 |
5.2 |
Spread time |
Time to evenly spread on skin |
<10 second |
8 |
6.5 |
6 |
Fig no.5: Spredabilty test
Spreadability directly affects patient compliance and the therapeutic effectiveness of the formulation, as better spreadability ensures uniform application and efficient absorption.The slip and drag method was used. The spreadability of the cinnamon-based roll-on was evaluated to ensure ease of application on the skin. A small quantity of the formulation was placed between two glass slides, and a standardized weight was applied for a fixed time. The area covered by the roll-on formulation was measured. The results showed that the roll-on spread smoothly and evenly without requiring excessive pressure. The formulation exhibited excellent spreadability, forming a uniform thin layer, which ensures effective coverage over the affected area. These results indicate that the cinnamon-based roll-on provides easy application and good skin adherence.
Table no. 10 : Microbial growth
Test |
F1 result |
F2 |
F3 |
Pathogen or microorganisms growth |
Absent |
Absent |
Absent |
Fig no.6 : Microbial test Fig no.7 : Laminar Air Flow
The microbial test was conducted to assess the safety and hygiene of the cinnamon-based roll-on formulation. The formulation was subjected to standard microbiological tests, including total microbial count. The results revealed that the total microbial count was within the permissible limits, and no pathogenic microorganisms were detected in the formulation. Confirming the antimicrobial efficacy of the formulation. These findings indicate that the cinnamon-based roll-on is microbiologically safe, free from harmful pathogens. The microbial load was found to be within acceptable limits, indicating good microbiological quality of the formulation.
CONCLUSION
The cinnamon roll-on formulation presents a novel, natural, and user-friendly approach to managing primary dysmenorrhoea. Its effectiveness, confirmed through key physicochemical and microbiological evaluations, highlights its safety, stability, and therapeutic value. Enriched with cinnamaldehyde and eugenol, the formulation offers targeted analgesic, anti-inflammatory, and antispasmodic action addressing the root causes of menstrual pain. The roll-on design enhances usability and ensures rapid, localized relief without systemic side effects. As a non-invasive alternative to oral medications, it aligns with the growing demand for safe, plant-based solutions in women’s health. With further clinical validation, this product holds strong potential for large-scale adoption and integration into modern menstrual care.
REFERENCES
Gangasagar Shinde*, Tanuja Langote, Aditya Unhale, Dr. Swati Deshmukh, Cinnamon-Enhanced Topical Roll-On: A Sustainable Solution for Dysmenorrhoea and Chronic Inflammation, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 5, 2687-2697. https://doi.org/10.5281/zenodo.15437946